Article
Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.
Journal of clinical microbiology - 1 Dec 2009
Bravo Lulette Tricia C, Tuohy Marion J, Ang Concepcion, Destura Raul V, Mendoza Myrna, Procop Gary W, Gordon Steven M, Hall Geraldine S, Shrestha Nabin K
Abstract excerpt
After isoniazid and rifampin (rifampicin), the next pivotal drug class in Mycobacterium tuberculosis treatment is the fluoroquinolone class. Mutations in resistance-determining regions (RDR) of the rpoB, katG, and gyrA genes occur with frequencies of 97%, 50%, and 85% among M. tuberculosis isolates resistant to rifampin, isoniazid, and fluoroquinolones, respectively. Sequences are highly conserved, and certain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
